• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ethica expands IRB services to Latin America

ethica expands IRB services to Latin America

October 6, 2008
CenterWatch Staff

ethica Clinical Research, a Montreal, Canada-based contract research organization (CRO), has partnered with Argentina-based Blanchard y Asociados to provide ethics review services for clinical trials in Latin America.

The services will be run through ethica’s recently renamed non-profit independent review board (IRB),Veritas IRB,making this one of the first Latin American IRBs to be accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

“We’re already conducting trials in Latin America as a CRO. By opening our office in Buenos Aires,Veritas IRB becomes the first accredited IRB in Argentina ... and this provides us with the assurance that research participants’ rights and welfare will be protected in the studies that we and others participate in. We can now offer to investigators an IRB that is accredited and we can rest assured when we’re conducting the trials that risk management is being handled properly,” said ethica founder and president Janice Parente.

This recent partnership is not the first global move for ethica, which began conducting clinical trials in Brazil in 2002, but the company is approaching its global growth carefully to ensure that appropriate study standards are upheld, Parente said.

“What our industry fails to understand is that some of these countries aren’t ready for research,” Parente explained. “We’re trying to teach our industry that you can do it right. You can still do it quickly, and you can enter these countries and do the trials but without exploiting those populations. There’s a proper way to do it.”

ethica tailors the services it provides in each country based on the particular country’s needs and capabilities. In India, for example, where ethica expanded its clinical trial management operations last year, the CRO is working to establish basic standards and education before it will begin conducting clinical trials.

“We’re taking it very slowly. Our first entry into that market is training.We’re starting to train researchers on how to be researchers, and we’re starting to train physicians on how to be investigators.We’re building the infrastructure of research so that we can actually conduct the trials. Right now, we are cautious about what trials we are conducting in India,” Parente said.

South America is different, Parente said, because clinical trials have been conducted there for many years.

“We just want to make sure we’re doing it correctly,” Parente said. The recent partnership with Blanchard enables ethica to do that.

Founded in 2002, ethica is the first and only CRO to be AAHRPP-accredited. In 2007, ethica partnered with Columbia, Md.-based Chesapeake Research Review to deliver collaborative ethics review services for clinical research conducted in the United States and Canada. The CRO plans to eventually expand to other areas, but that expansion is a long way off, Parente said. “Right now, we’re where we want to be, and from Canada, South America, and Asia, being India, we seem to be able to control our growth.”

Upcoming Events

  • 12Apr

    The Participant Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing